Haris Mohamed: Esophageal Injury Following Capsule Manipulation in a Young Patient Receiving Dabigatran
Haris Mohamed, Inpatient Pharmacist at Abu Dhabi Stem Cells Center, shared a post on LinkedIn:
“She opened her capsule.
Mixed it with honey.
Swallowed it.
She was trying to help herself.
Three days later, she was vomiting blood.
A 19-year-old with Cerebral Venous Sinus Thrombosis – prescribed with dabigatran 150 mg twice daily.
Good diagnosis.
Correct drug.
Right dose.
But nobody told her the capsule could never be opened.
Here is what happened:
Dabigatran capsules contain tartaric acid-coated pellets.
That acid is not a filler — it creates the right environment for absorption.
The capsule shell carries those pellets safely past the Esophagus.
When she opened it, the pellets hit her Esophageal lining directly.
The pH dropped. The tissue burned.
Ulcers formed.
Then dabigatran made sure they bled freely.
Her body also absorbed 75% more drug than intended.
Maximum anticoagulation. Active bleeding.
No clotting protection.
Honey made it worse — it kept the pellets against the Esophageal wall longer.
She recovered.
But here is what stays with me:
Nobody failed dramatically.
A young woman didn’t know one rule.
And no one made sure she did.
This doesn’t only happen at home.
Pharmacists — check your inpatient orders.
Because these two orders exist in hospitals right now:
‘Dabigatran 75 mg — give ½ of a 150 mg capsule’
The 75 mg capsule is approved and available. If it is on your formulary, there is never a reason to split a 150 mg capsule.
Same order — when 75 mg is not on formulary
If the 75 mg capsule is not stocked, splitting the 150 mg is still not the answer.
Escalate to procurement, consult the prescriber — opening that capsule is never an acceptable workaround.
Both orders look like a dose adjustment.
Neither is safe.
Pellets don’t distribute evenly — ‘half’ is not half.
And a nurse handed either order will open the capsule, meaning well, causing harm.
When you see that order:
Do not dispense it
- Call the prescriber. Clarify the dose.
- 75 mg on formulary — switch to it. Document the intervention.
- 75 mg not on formulary — escalate to procurement. Never split.
- Inform nursing — this capsule is never opened
The villain is not the drug.
It is the gap between ‘prescribed correctly’ and ‘taken correctly.’
That gap lives in the skipped discharge conversation.
In the unreviewed inpatient order.
In the assumption that a young patient will figure it out.
Pharmacists sit right in that gap.
Use the position.
Never open, crush, split, or chew – ever
- Full glass of water. Every dose. With food.
- Upright for 30–60 minutes after
- Swallowing difficulty: flag it, don’t improvise
- Need 75 mg? Prescribe it — or escalate if not on formulary.
One conversation.
One intercepted order.
That is the difference.
Case details anonymized for educational purposes.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy